相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Genomic expression profiling across the pediatric systemic inflammatory response syndrome, sepsis, and septic shock spectrum
Hector R. Wong et al.
CRITICAL CARE MEDICINE (2009)
Interleukin-8 as a stratification tool for interventional trials involving pediatric septic shock
Hector R. Wong et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Validating the genomic signature of pediatric septic shock
Natalie Cvijanovich et al.
PHYSIOLOGICAL GENOMICS (2008)
Immunoparalysis and adverse outcomes from critical illness
W. Joshua Frazier et al.
PEDIATRIC CLINICS OF NORTH AMERICA (2008)
Distinct hemodynamic patterns of septic shock at presentation to pediatric intensive care
Joe Brierley et al.
PEDIATRICS (2008)
Genome-level longitudinal expression of signaling pathways and gene networks in pediatric septic shock
Thomas P. Shanley et al.
MOLECULAR MEDICINE (2007)
Genome-level expression profiles in pediatric septic shock indicate a role for altered zinc homeostasis in poor outcome
Hector R. Wong et al.
PHYSIOLOGICAL GENOMICS (2007)
Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial
Simon Nadel et al.
LANCET (2007)
What is a support vector machine?
William S. Noble
NATURE BIOTECHNOLOGY (2006)
Heterogeneity and prediction of hemodynamic responses to dobutamine in patients with septic shock
Wilbert T. Jellema et al.
CRITICAL CARE MEDICINE (2006)
Pro-Con Debate: Steroid use in ACTH non-responsive septic shock patients with high baseline cortisol levels
Djillali Annane et al.
CRITICAL CARE (2006)
Microarray data analysis: from disarray to consolidation and consensus
DB Allison et al.
NATURE REVIEWS GENETICS (2006)
A network-based analysis of systemic inflammation in humans
SE Calvano et al.
NATURE (2005)
Application of genome-wide expression analysis to human health and disease
JP Cobb et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepis and multiple organ failure
KA Felmet et al.
JOURNAL OF IMMUNOLOGY (2005)
PCA in studying coordination and variability: a tutorial
A Daffertshofer et al.
CLINICAL BIOMECHANICS (2004)
Reprogramming of the immune system during zinc deficiency
PJ Fraker et al.
ANNUAL REVIEW OF NUTRITION (2004)
Role of apoptotic cell death in sepsis
RS Hotchkiss et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2003)
Is low monocyte HLA-DR expression helpful to predict outcome in severe sepsis?
SE Perry et al.
INTENSIVE CARE MEDICINE (2003)
Measures, markers, and mediators: Toward a staging system for clinical sepsis. A Report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25-26, 2000
JC Marshall et al.
CRITICAL CARE MEDICINE (2003)
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
RA Irizarry et al.
BIOSTATISTICS (2003)
The epidemiology of severe sepsis in children in the United States
RS Watson et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Medical progress: The pathophysiology and treatment of sepsis.
RS Hotchkiss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
A gene-expression signature as a predictor of survival in breast cancer.
MJ van de Vijver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
A Rosenwald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Statistical issues with microarrays: processing and analysis
R Nadon et al.
TRENDS IN GENETICS (2002)
Multiclass cancer diagnosis using tumor gene expression signatures
S Ramaswamy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study
K Reinhart et al.
CRITICAL CARE MEDICINE (2001)